Kong Yan-Jun, Yi Hong-Gang, Dai Jun-Cheng, Wei Mu-Xin
Yan-Jun Kong, Division of Traditional Chinese Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
World J Gastroenterol. 2014 May 21;20(19):5903-11. doi: 10.3748/wjg.v20.i19.5903.
To systematically review pathological changes of gastric mucosa in gastric atrophy (GA) and intestinal metaplasia (IM) after Helicobacter pylori (H. pylori) eradication.
A systematic search was made of PubMed, Web of Science, EMBASE, ClinicalTrials.gov, OVID and the Cochran Library databases for articles published before March 2013 pertaining to H. pylori and gastric premalignant lesions. Relevant outcomes from articles included in the meta-analysis were combined using Review Manager 5.2 software. A Begg's test was applied to test for publication bias using STATA 11 software. χ(2) and I(2) analyses were used to assess heterogeneity. Analysis of data with no heterogeneity (P > 0.1, I (2) < 25%) was carried out with a fixed effects model, otherwise the causes of heterogeneity were first analyzed and then a random effects model was applied.
The results of the meta-analysis showed that the pooled weighted mean difference (WMD) with 95%CI was 0.23 (0.18-0.29) between eradication and non-eradication of H. pylori infection in antral IM with a significant overall effect (Z = 8.19; P <0.00001) and no significant heterogeneity (χ(2) = 27.54, I(2) = 16%). The pooled WMD with 95%CI was -0.01 (-0.04-0.02) for IM in the corpus with no overall effect (Z = 0.66) or heterogeneity (χ(2) = 14.87, I(2) =0%) (fixed effects model). In antral GA, the pooled WMD with 95% CI was 0.25 (0.15-0.35) with a significant overall effect (Z = 4.78; P < 0.00001) and significant heterogeneity (χ(2) = 86.12, I(2) = 71%; P < 0.00001). The pooled WMD with 95% CI for GA of the corpus was 0.14 (0.04-0.24) with a significant overall effect (Z = 2.67; P = 0.008) and significant heterogeneity (χ(2) = 44.79, I(2) = 62%; P = 0.0003) (random effects model).
H. pylori eradication strongly correlates with improvement in IM in the antrum and GA in the corpus and antrum of the stomach.
系统评价幽门螺杆菌(H. pylori)根除治疗后胃萎缩(GA)和肠化生(IM)患者胃黏膜的病理变化。
系统检索PubMed、Web of Science、EMBASE、ClinicalTrials.gov、OVID和Cochrane图书馆数据库,查找2013年3月之前发表的有关H. pylori与胃癌前病变的文章。使用Review Manager 5.2软件合并纳入荟萃分析的文章的相关结果。应用Begg检验,使用STATA 11软件检验发表偏倚。采用χ(2)和I(2)分析评估异质性。对无异质性的数据(P>0.1,I(2)<25%)采用固定效应模型进行分析,否则先分析异质性原因,再应用随机效应模型。
荟萃分析结果显示,胃窦部IM中,根除与未根除H. pylori感染之间的合并加权平均差(WMD)及其95%置信区间为0.23(0.18 - 0.29),总体效应显著(Z = 8.19;P<0.00001),且无显著异质性(χ(2)=27.54,I(2)=16%)。胃体部IM的合并WMD及其95%置信区间为 - 0.01( - 0.04 - 0.02),无总体效应(Z = 0.66)或异质性(χ(2)=14.87,I(2)=0%)(固定效应模型)。胃窦部GA的合并WMD及其95%置信区间为0.25(0.15 - 0.35),总体效应显著(Z = 4.78;P<0.00001),且异质性显著(χ(2)=86.12,I(2)=71%;P<0.00001)。胃体部GA的合并WMD及其95%置信区间为0.14(0.04 - 0.24),总体效应显著(Z = 2.67;P = 0.008),且异质性显著(χ(2)=44.79,I(2)=62%;P = 0.0003)(随机效应模型)。
根除H. pylori与胃窦部IM及胃体部和胃窦部GA的改善密切相关。